tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AZNCF Stock Latest News

AstraZeneca’s Promising Non-Oncology Pipeline and Baxdrostat’s Market Potential Drive Buy Rating
RatingsAstraZeneca’s Promising Non-Oncology Pipeline and Baxdrostat’s Market Potential Drive Buy Rating
5h ago
AZN
AstraZeneca Announces Current Share Capital and Voting Rights
PremiumCompany Announcements
AstraZeneca Announces Current Share Capital and Voting Rights
16h ago
AstraZeneca: Strong Market Position and Growth Potential Justify Buy Rating
PremiumRatings
AstraZeneca: Strong Market Position and Growth Potential Justify Buy Rating
20h ago
AZN
AstraZeneca’s Promising Outlook: Buy Rating Backed by Baxdrostat’s Potential and Strategic Positioning
PremiumRatings
AstraZeneca’s Promising Outlook: Buy Rating Backed by Baxdrostat’s Potential and Strategic Positioning
1d ago
AZN
AstraZeneca reports baxdrostat met primary, secondary endpoints in Phase 3 trial
PremiumThe Fly
AstraZeneca reports baxdrostat met primary, secondary endpoints in Phase 3 trial
2d ago
AZN
AstraZeneca’s Promising Hypertension Breakthrough: Analyst Recommends Buy Ahead of Phase III Data Presentation
PremiumRatingsAstraZeneca’s Promising Hypertension Breakthrough: Analyst Recommends Buy Ahead of Phase III Data Presentation
4d ago
AZN
AstraZeneca Clarifies TR-1 Notification Error
Premium
Company Announcements
AstraZeneca Clarifies TR-1 Notification Error
5d ago
AstraZeneca’s New Asthma Study: Potential Market Impact
Premium
Company Announcements
AstraZeneca’s New Asthma Study: Potential Market Impact
11d ago
AZN
AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment
11d ago
AZN
AstraZeneca’s ARISE Study: Real-World Insights on Acalabrutinib for CLL
PremiumCompany Announcements
AstraZeneca’s ARISE Study: Real-World Insights on Acalabrutinib for CLL
11d ago
AZN
AstraZeneca’s Innovative Lung Cancer Screening Study: A Game Changer for Early Detection
PremiumCompany Announcements
AstraZeneca’s Innovative Lung Cancer Screening Study: A Game Changer for Early Detection
11d ago
AZN
AstraZeneca’s AZD9829 Study: A New Hope in Hematological Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s AZD9829 Study: A New Hope in Hematological Cancer Treatment
11d ago
AZN
AstraZeneca’s New Study on Tezepelumab for CRSwNP: A Potential Game-Changer
PremiumCompany AnnouncementsAstraZeneca’s New Study on Tezepelumab for CRSwNP: A Potential Game-Changer
11d ago
AZN
Amgen and AstraZeneca Launch Promising Phase 3 Lung Cancer Study
Premium
Company Announcements
Amgen and AstraZeneca Launch Promising Phase 3 Lung Cancer Study
11d ago
AZN
AMGN
AstraZeneca’s CHRONICLES COPD Study: A New Horizon in COPD Treatment
Premium
Company Announcements
AstraZeneca’s CHRONICLES COPD Study: A New Horizon in COPD Treatment
12d ago
AZN
AstraZeneca’s New CAR T-Cell Therapy Study: A Potential Game-Changer for Multiple Myeloma
PremiumCompany Announcements
AstraZeneca’s New CAR T-Cell Therapy Study: A Potential Game-Changer for Multiple Myeloma
12d ago
AZN
AstraZeneca’s New Study on Crohn’s Disease Treatment: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s New Study on Crohn’s Disease Treatment: Key Insights for Investors
12d ago
AZN
AstraZeneca’s Phase III COPD Study: A Potential Game-Changer in Respiratory Treatment
PremiumCompany Announcements
AstraZeneca’s Phase III COPD Study: A Potential Game-Changer in Respiratory Treatment
12d ago
AZN
AstraZeneca’s GEMINI-PeriOp GC Study: A New Frontier in Gastroesophageal Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s GEMINI-PeriOp GC Study: A New Frontier in Gastroesophageal Cancer Treatment
12d ago
AZN
PRXL
The Capital Group Adjusts AstraZeneca Holdings
PremiumCompany AnnouncementsThe Capital Group Adjusts AstraZeneca Holdings
12d ago
AstraZeneca’s Benralizumab Study Completes: A Potential Game-Changer for COPD Treatment
Premium
Company Announcements
AstraZeneca’s Benralizumab Study Completes: A Potential Game-Changer for COPD Treatment
13d ago
AZN
AstraZeneca’s Atuliflapon Study: A New Hope for Uncontrolled Asthma
Premium
Company Announcements
AstraZeneca’s Atuliflapon Study: A New Hope for Uncontrolled Asthma
13d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >